| 摘要: |
| 糖尿病心肌病(Diabetic cardiomyopathy,DCM)是糖尿病(Diabetes mellitus,DM)恶化到一定阶段后出现的心血管并发症。纤维化是其中重要的病理重构,主要由心脏成纤维细胞(Cardiac fibroblasts,CFs)参与。TRPM7(Transient receptor potential melastatin-subfamily member 7)是一种具有阳离子通道和蛋白激酶双重结构的膜蛋白,组成性表达于心脏成纤维细胞中。TRPM7在糖尿病心肌纤维化的病理过程中发挥着重要作用,能够通过影响转化生长因子β1(Transforming growth factor β1,TGF-β1)的表达、肾素-血管紧张素-醛固酮系统(Renin-angiotensin-aldosterone system,RAAS)的活化、Ca2+的信号转导和Mg2+的代谢,从而影响糖尿病心肌纤维化的发展进程。本文综述TRPM7在糖尿病心肌纤维化中的广泛和重要作用,并关注了其作为减轻纤维发生的治疗靶点的潜力。 |
| 关键词: 糖尿病心肌病 心脏纤维化 成纤维细胞 TRPM7 |
| DOI:10.13506/j.cnki.jpr.2023.05.007 |
| 基金项目:国家科技重大专项(No.2017ZX09301066) |
|
出版日期:2023-05-25
|
|
| Role of TRPM7 in diabetic myocardial fibrosis |
| JIANG Yifeng,TANG Yiqun |
| (China Pharmaceutical University, Nanjing 211198, China) |
| Abstract: |
| Diabetic cardiomyopathy (DCM) is a cardiovascular complication after diabetes mellitus (DM) develops to a certain stage. Fibrosis is one of the important pathological reconstruction, which mainly involving cardiac fibroblasts (CFs). TRPM7 (Transient receptor potential mela statin-subfamily member 7) is a membrane protein with dual structure of cation channel and protein kinase, which is constitutively expressed in cardiac fibroblasts. TRPM7 plays an important role in the pathological process of diabetic cardiac fibrosis. It can impact the development of diabetic cardiac fibrosis by influencing expression of transforming growth factor β1(TGF-β1), activation of renin-angiotensin-aldosterone system (RAAS), signal transduction of Ca2+ and metabolization of Mg2+. This article discussed the extensive and important role of TRPM7 in diabetic cardiac fibrosis, and pays attention to its potential as a therapeutic target to reduce fibrosis. |
| Key words: Diabetic cardiomyopathy Myocardial fibrosis Fibroblast TRPM7 |